# STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial

> **NCT04491617** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 129 (actual)

## Conditions studied

- Postoperative Pain
- Opioid Use
- Prolapse; Female
- Incontinence

## Interventions

- **OTHER:** Standard opioid prescribing
- **OTHER:** Restrictive opioid prescribing

## Key facts

- **NCT ID:** NCT04491617
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-27
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04491617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04491617, "STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04491617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*